ProTip receives European award for biomaterial research program
24 October 2011
Strasbourg-based ProTip SA, a developer of devices for
dysfunctions of the larynx, has won the ESB Translational Research prize
of the European Society for Biomaterials.
The prize, sponsored by the Swiss Society for Biomaterials, is
designed to support scientific efforts in translational research. It
was awarded at the ESB annual congress in Dublin last month.
This prize has been awarded for a research program launched by
ProTip in 2010, aimed at developing a trachea implant made from a
biodegradable microporous polymer and macroporous titanium.
This program is being led by Dr. Nihal Engin Vrana, a post-doctorate
researcher specialized in the development of biomaterials that is
now working for ProTip. The program is also in association with the
Inserm Biomaterials and Tissue Engineering laboratory in Strasbourg.
This distinction confirms ProTip’s proven potential for developing
an innovative solution based on porous titanium for thousands of
patients who have undergone a partial or total laryngectomy.
“We are very proud to have been awarded this particular prize, as it
is a strong mark of peer recognition,” said Dr. Nihal Engin Vrana,
who presented the ProTip project at the ESB congress. “The award
demonstrates recognition for our ability to undertake a research
program that generates concrete solutions for patients, while
maintaining high scientific standards. It is also proof that ProTip
knows how to balance its short-term corporate goals with the
long-term scientific objectives of Inserm.” Inserm is the French
National Health and Medical Research Institute.
proves that, with high enough focus on relevant and the right
research activities, a young firm like ProTip can play an important
role in a market as demanding and competitive as that of
biomaterials,” said the chairman of ProTip SA, Maurice Bérenger.